Skip to content

Edwards Lifesciences Corp Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: November 4, 2026 results vs estimates

Edwards Lifesciences Corp · E.EW.NYSE · United States
Use symbol E.EW.NYSE in our API & Excel add-in to retrieve this data ↓
94.44
(+0.03%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 100%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 22.39%

Edwards Lifesciences Corp Forecast

Edwards Lifesciences Corp short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 22.4% a year, a typical one-standard-deviation range is 91.46–97.42 over a week, 88.34–100.54 over a month and 73.29–115.59 over a year. (Signals as of 1 Nov 2026.)

Edwards Lifesciences Corp Price Chart

MacroFinance.ai

Edwards Lifesciences Corp Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Edwards Lifesciences Corp
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Edwards Lifesciences Corp
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Edwards Lifesciences Corp
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Edwards Lifesciences Corp
P/E
53.41x
Stretched vs own history
QoQ +3.5%
YoY +46.5%
now 53.410932.49 low60.6 high
ⓘP/E As of 22 Nov 2026.See Edwards Lifesciences Corp returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Edwards Lifesciences Corp
P/S
8.17x
Mid-range vs own history
QoQ +2.6%
YoY −3.6%
now 8.17247.37 low9.27 high
ⓘP/S As of 22 Nov 2026.See Edwards Lifesciences Corp returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Edwards Lifesciences Corp
P/B
5.02x
Mid-range vs own history
QoQ +2.8%
YoY +2.8%
now 5.02244.35 low5.7 high
ⓘP/B As of 22 Nov 2026.See Edwards Lifesciences Corp returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Edwards Lifesciences Corp
EV/EBITDA
42.82x
Stretched vs own history
QoQ +40.3%
YoY +61.5%
now 42.819523.44 low49.03 high
ⓘEV/EBITDA As of 22 Nov 2026.See Edwards Lifesciences Corp returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Edwards Lifesciences Corp
EV/Sales
7.58x
Mid-range vs own history
QoQ +2.2%
YoY −4.5%
now 7.58216.89 low8.68 high
ⓘEV/Sales As of 22 Nov 2026.See Edwards Lifesciences Corp returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Edwards Lifesciences Corp
FCF Yield
2.6%
Strong vs own history
QoQ −5.6%
YoY +7.9%
now 2.61071.99 low2.95 high
ⓘFCF Yield As of 22 Nov 2026.See Edwards Lifesciences Corp returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Edwards Lifesciences Corp
Earnings Yield
1.9%
Weak vs own history
QoQ −3.4%
YoY −31.8%
now 1.87231.65 low3.08 high
ⓘEarnings Yield As of 22 Nov 2026.See Edwards Lifesciences Corp returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Edwards Lifesciences Corp
Market Cap
$54.5B
Mid-range vs own history
QoQ +5.2%
YoY +9.4%
now 54548.54444,437 low61,890 high
ⓘMarket Cap As of 22 Nov 2026.See Edwards Lifesciences Corp returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Edwards Lifesciences Corp
Net Debt
-$3.9B
Low vs own history
QoQ +11.0%
YoY +25.4%
now -3940.2-3,940 low-2,970 high
ⓘNet Debt As of 22 Nov 2026.See Edwards Lifesciences Corp returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Edwards Lifesciences Corp
Net Debt / EBITDA
-3.33x
Low vs own history
QoQ +48.7%
YoY +86.9%
now -3.3338-3.33 low-1.78 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Edwards Lifesciences Corp returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Edwards Lifesciences Corp
Current Ratio
4.60x
Strong vs own history
QoQ +1.6%
YoY +14.8%
now 4.59663.72 low4.6 high
ⓘCurrent Ratio As of 22 Nov 2026.See Edwards Lifesciences Corp returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Edwards Lifesciences Corp
Quick Ratio
3.86x
Strong vs own history
QoQ +2.4%
YoY +17.5%
now 3.86133.09 low3.86 high
ⓘQuick Ratio As of 22 Nov 2026.See Edwards Lifesciences Corp returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Edwards Lifesciences Corp
Debt / Equity
0.06x
Low vs own history
QoQ −2.2%
YoY −5.4%
now 0.06490.06 low0.07 high
ⓘDebt / Equity As of 22 Nov 2026.See Edwards Lifesciences Corp returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Edwards Lifesciences Corp
Piotroski F-Score
7
Mid-range vs own history
QoQ +40.0%
YoY +16.7%
now 75 low7 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Edwards Lifesciences Corp returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Edwards Lifesciences Corp
Altman Z-Score
13.11
Mid-range vs own history
QoQ +3.5%
YoY +4.7%
now 13.107410.72 low14.49 high
ⓘAltman Z-Score As of 22 Nov 2026.See Edwards Lifesciences Corp returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  19 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  21 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Edwards Lifesciences Corp, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Edwards Lifesciences Corp fundamentals: income statement, balance sheet & cash flow

Edwards Lifesciences Corp reported revenue of $6.07bn and net income of $1.07bn in FY2025, the year ended 31 December 2025 — revenue up 11.5% and net income down 74.3% on the prior year. Free cash flow was $1.34bn. These figures are as reported in the filings, not restated: 27 fiscal years and 108 quarters of history, back to December 1999. 173 FINRA short-interest settlements are published alongside them, back to June 2019.

Revenue (FY2025)
$6.07bn
+11.5%
Net income
$1.07bn
-74.3%
Gross margin
78.13%
Free cash flow
$1.34bn
+360.5%
Net debt
-$2.23bn
Shares short (30 Oct 2026)
9.38m
2.80 days to cover
Edwards Lifesciences Corp income statement, annual, as reported · USD millions unless stated
USD millionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue6,067.65,439.56,004.85,382.45,232.5
Cost of revenue1,326.91,117.51,379.81,167.21,225.9
Gross profit4,740.74,322.04,625.04,215.24,006.6
Research & development1,079.21,053.01,071.8945.2903.1
Selling, general & admin.———1,566.51,494.0
Operating income1,636.21,378.71,534.11,702.41,610.4
EBITDA1,429.51,723.11,534.11,933.21,861.6
Interest expense20.419.817.626.224.8
Pre-tax income1,272.91,548.11,598.11,767.41,702.0
Income tax216.9152.1198.7245.5198.9
Net income1,073.54,174.61,402.41,521.91,503.1

Download Edwards Lifesciences Corp fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.EW.NYSE&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 27 fiscal years and 108 quarters, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on Edwards Lifesciences Corp

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Edwards Lifesciences Corp Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Edwards Lifesciences Corp; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Edwards Lifesciences Corp’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Edwards Lifesciences Corp behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Edwards Lifesciences Corp (United States)

Edwards Lifesciences Corp is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on East West Banking Corp

Frequently asked questions

What is Edwards Lifesciences Corp?
Edwards Lifesciences Corp is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Edwards Lifesciences Corp price?
The latest close is 94.44 (1 Nov 2026), +0.03% on the day. The price at the top of the page refreshes during the trading day.
Is Edwards Lifesciences Corp in an uptrend?
As of 1 Nov 2026, short-term momentum is strongly positive (4 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Edwards Lifesciences Corp?
20-day realised volatility is 22.4% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 6.5% over a month and 3.2% over a week.
What factors affect Edwards Lifesciences Corp?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Edwards Lifesciences Corp, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Edwards Lifesciences Corp?
58 backtested tactical asset allocation strategies trade Edwards Lifesciences Corp through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Edwards Lifesciences Corp returns analysed?
The Statistical Distribution of Returns section shows the distribution of Edwards Lifesciences Corp daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Edwards Lifesciences Corp historical data?
In the Free historical data section of this page: the last 10 years of Edwards Lifesciences Corp daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Edwards Lifesciences Corp historical data (last 10 years)

Browse or instantly download the last 10 years of Edwards Lifesciences Corp daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.EW.NYSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20101.85
2026-11-19103.88
2026-11-18105.23
2026-11-17105.43
2026-11-16107.11
2026-11-13107.15
2026-11-12105.8
2026-11-11105.81
2026-11-10104.01
2026-11-09104.71
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.